Turkey's health minister said Monday that the country is using a drug sent from China on patients suffering from the novel coronavirus.
"From this morning we have brought a special drug used in China which is claimed to have resulted in improvements in intensive care patients, cutting their time in care from 11-12 days to four days," Fahrettin Koca told reporters.
He did not give more information on the drug but the anti-malarial drug chloroquine has recently been used to treat coronavirus patients in China as well as France.
Some researchers have said chloroquine shows great promise, though scientists have agreed that only more trials would determine if it really works and is safe.
According to figures released late Sunday, Turkey has officially recorded 1,236 coronavirus cases and 30 deaths.
Koca said 50,000 rapid detection kits had arrived from China on Monday and had begun to be used, with 300,000 expected by Thursday.
The minister added that the Chinese government agreed with Turkey to share information on the novel coronavirus as the two countries step up cooperation to fight against the virus.
While Koca did not detail where the positive cases were in Turkey, he said the virus had spread across the country.
He did say there were fewer than 10 cases in Turkey's Van province, which borders badly-hit Iran.
He also said some health workers had caught the coronavirus, without giving specific figures.
A further 32,000 health workers would be employed during the crisis, he told a press conference in Ankara.
Koca also said that face masks produced in Turkey "will not be exported" as the country was in need.
There had been speculation Koca might announce a state of emergency, but he urged Turks to "announce their own state of emergency" as he insisted citizens adhere to measures already announced by Ankara.
Turkish authorities have ordered those aged 65 and above and those with chronic illnesses to stay at home, while most public spaces have been temporarily shut.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
